Virus News and Research

Latest Virus News and Research

Omicron vaccine breakthrough infections induce potent cross-reactive antibodies

In a recent study published in the journal Cell, researchers demonstrated that antibodies generated due to breakthrough infection (BTI) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) new variant of concern (VOC) Omicron in vaccinated individuals could neutralize all VOCs.

24 May 2022

Biologic medications used by IBD patients boost COVID-19 vaccine response

Getting the COVID-19 vaccination strengthened one type of immune response to the SARS-CoV-2 virus in inflammatory bowel disease (IBD) patients even though they were taking immunosuppressant medication, according to investigators at Cedars-Sinai.

23 May 2022

Studies find breakthrough SARS-CoV-2 Infections are more likely in cancer and Alzheimer's patients

Breakthrough COVID-19 cases resulting in infections, hospitalizations and deaths are significantly more likely in cancer and Alzheimer's patients, according to two new studies from researchers at the Case Western Reserve University School of Medicine.

23 May 2022

Emergency department plays vital role in investigating the accuracy of COVID-19 diagnostic tests

The Department of Emergency Medicine at Washington University School of Medicine in St. Louis played a key role in investigating the accuracy of many different types of COVID-19 diagnostic tests administered in real-life conditions.

23 May 2022

Emergence of monkeypox: Control measures and concerns

Monkeypox, a virus that causes pus-filled blisters, has been detected in several countries, including the United States, Canada, Australia and some European nations.

23 May 2022

CDC scientists partner with Massachusetts Department of Public Health to investigate a monkeypox case

Scientists at the Centers for Disease Control and Prevention (CDC) are collaborating with the Massachusetts Department of Public Health to investigate a case of monkeypox in a Massachusetts resident who had recently traveled to Canada by private transportation.

23 May 2022

Study suggests that recall of B cell memory may depend on relative locations of prime and boost immunization

A new study investigated whether a specific population of local Bmem cells in the proximal LNs produce secondary GC responses that are different from those at distal sites and if the location in humoral immunity is relevant only to nonlymphoid tissues.

23 May 2022

Study reports SARS-CoV-2 accessory proteins downregulate MHC-I expression using distinct mechanisms

Researchers observed SARS-CoV-2 downregulates the expression of MHC class I molecules.

23 May 2022

Real-world vaccine effectiveness of mRNA-1273 and BNT1262b2 in immunocompromised adults

Researchers assessed the efficacy of COVID-19 vaccines in immunocompromised adults.

23 May 2022

Improving Patient Recruitment for Clinical Trial Research

In this interview, we speak to Matt Walz, CEO of Trialbee, about the importance of improving patient recruitment and retention within clinical trials.

From Trialbee 23 May 2022

First draft genome sequence of the Monkeypox virus associated with major outbreak

In a recent study posted to the Virological discussion forum, researchers revealed a draft genome sequence of the monkeypox virus associated with a recent outbreak in Portugal.

23 May 2022

Repurposed drug clofoctol blocks SARS-CoV-2 replication in mouse study

A new paper presents the results of a mouse study using the repurposed antibacterial drug clofoctol against this virus.

23 May 2022

The interaction between genetics and the impact of the COVID-19 pandemic on individuals’ wellbeing over time

The study examined how genetics affected the physical and mental health and behavioral patterns related to lifestyle, using data from the Lifelines biobank.

23 May 2022

Tiny shark-derived antibodies broadly neutralize most SARS-CoV-2 variants

Resarchers discuss the ability of shark-derived antibodies to protect against multiple variants of SARS-CoV-2.

23 May 2022

Can human coronaviruses infect the GI tract?

Researchers review current findings on how human coronaviruses like SARS-CoV-2 might cause GI symptoms.

22 May 2022

Study reveals how ZBP1 could lead to a cytokine storm during COVID-19

Scientists from St. Jude Children's Research Hospital have shown that the innate immune sensor, ZBP1, and its associated inflammatory cell death pathway, PANoptosis, are major contributors to the negative effects of interferon treatment and high interferon levels in some COVID-19 patients.

20 May 2022

Research provides new insight into how Crimean-Congo hemorrhagic fever virus causes disease

Army scientists determined that the body's own natural immune response contributes to disease severity in mice infected with Crimean-Congo hemorrhagic fever virus (CCHFV), which causes a widespread tick-borne viral infection in humans.

20 May 2022

Researchers discover how one type of T cell creates functionally distinct, but genetically identical daughter cells

Scientists at St. Jude Children's Research Hospital have solved an immunology puzzle. A CD8+ T cell can have two functionally distinct daughter cells after it divides, despite the cells being genetically identical.

20 May 2022

UNC-Chapel Hill secures $65 million NIH grant for establishing Antiviral Drug Discovery Center

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health awarded the UNC Gillings School of Global Public Health a $65 million grant establishing an Antiviral Drug Discovery Center to develop oral antivirals that can combat pandemic-level viruses like COVID-19.

20 May 2022

G7 health ministers sign landmark pact to make the world better prepared for future pandemics

A landmark pact signed by G7 health ministers in Berlin will help ensure the world is better prepared for future pandemics.

20 May 2022

Virus News and Research

Latest Virus News and Research

Omicron vaccine breakthrough infections induce potent cross-reactive antibodies

Biologic medications used by IBD patients boost COVID-19 vaccine response

Studies find breakthrough SARS-CoV-2 Infections are more likely in cancer and Alzheimer's patients

Emergency department plays vital role in investigating the accuracy of COVID-19 diagnostic tests

Emergence of monkeypox: Control measures and concerns

CDC scientists partner with Massachusetts Department of Public Health to investigate a monkeypox case

Study suggests that recall of B cell memory may depend on relative locations of prime and boost immunization

Study reports SARS-CoV-2 accessory proteins downregulate MHC-I expression using distinct mechanisms

Real-world vaccine effectiveness of mRNA-1273 and BNT1262b2 in immunocompromised adults

Improving Patient Recruitment for Clinical Trial Research

First draft genome sequence of the Monkeypox virus associated with major outbreak

Repurposed drug clofoctol blocks SARS-CoV-2 replication in mouse study

The interaction between genetics and the impact of the COVID-19 pandemic on individuals’ wellbeing over time

Tiny shark-derived antibodies broadly neutralize most SARS-CoV-2 variants

Can human coronaviruses infect the GI tract?

Study reveals how ZBP1 could lead to a cytokine storm during COVID-19

Research provides new insight into how Crimean-Congo hemorrhagic fever virus causes disease

Researchers discover how one type of T cell creates functionally distinct, but genetically identical daughter cells

UNC-Chapel Hill secures $65 million NIH grant for establishing Antiviral Drug Discovery Center

G7 health ministers sign landmark pact to make the world better prepared for future pandemics

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in